<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gilley J</submitter><funding>Medical Research Council</funding><funding>Motor Neurone Disease Association</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>10-16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5640801</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>Studies with the Wld&lt;sup>S&lt;/sup> mutant mouse have shown that axon and synapse pathology in several models of neurodegenerative diseases are mechanistically related to injury-induced axon degeneration (Wallerian degeneration). Crucially, an absence of SARM1 delays Wallerian degeneration as robustly as Wld&lt;sup>S&lt;/sup>, but their relative capacities to confer long-term protection against related, non-injury axonopathy and/or synaptopathy have not been directly compared. While Sarm1 deletion or Wld&lt;sup>S&lt;/sup> can rescue perinatal lethality and widespread Wallerian-like axonopathy in young NMNAT2-deficient mice, we report that an absence of SARM1 enables these mice to survive into old age with no overt phenotype, whereas those rescued by Wld&lt;sup>S&lt;/sup> invariantly develop a progressive neuro</pubmed_abstract><journal>Cell reports</journal><pubmed_title>Sarm1 Deletion, but Not Wld&lt;sup>S&lt;/sup>, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy.</pubmed_title><pmcid>PMC5640801</pmcid><funding_grant_id>RIBCHESTER/APR15/838-791</funding_grant_id><funding_grant_id>BBS/E/B/000C0433</funding_grant_id><funding_grant_id>MR/M024075/1</funding_grant_id><funding_grant_id>MR/N004582/1</funding_grant_id><funding_grant_id>G1000702</funding_grant_id><pubmed_authors>Ribchester RR</pubmed_authors><pubmed_authors>Coleman MP</pubmed_authors><pubmed_authors>Gilley J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sarm1 Deletion, but Not Wld&lt;sup>S&lt;/sup>, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy.</name><description>Studies with the Wld&lt;sup>S&lt;/sup> mutant mouse have shown that axon and synapse pathology in several models of neurodegenerative diseases are mechanistically related to injury-induced axon degeneration (Wallerian degeneration). Crucially, an absence of SARM1 delays Wallerian degeneration as robustly as Wld&lt;sup>S&lt;/sup>, but their relative capacities to confer long-term protection against related, non-injury axonopathy and/or synaptopathy have not been directly compared. While Sarm1 deletion or Wld&lt;sup>S&lt;/sup> can rescue perinatal lethality and widespread Wallerian-like axonopathy in young NMNAT2-deficient mice, we report that an absence of SARM1 enables these mice to survive into old age with no overt phenotype, whereas those rescued by Wld&lt;sup>S&lt;/sup> invariantly develop a progressive neuro</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2025-04-22T21:15:59.961Z</modification><creation>2019-03-27T02:58:58Z</creation></dates><accession>S-EPMC5640801</accession><cross_references><pubmed>28978465</pubmed><doi>10.1016/j.celrep.2017.09.027</doi></cross_references></HashMap>